Abeona Therapeutics Inc.

NASDAQ: ABEO · Real-Time Price · USD
7.13
-0.10 (-1.38%)
At close: Aug 15, 2025, 3:07 PM

Abeona Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-63.73M -54.19M -39.7M -84.94M
Depreciation & Amortization
2.91M 3.2M 4.58M 4.46M
Stock-Based Compensation
6.63M 4.77M 3.05M 8.92M
Other Working Capital
-1.68M -3.83M 1.6M -7K
Other Non-Cash Items
2.57M 11M -5.52M -6.55M
Deferred Income Tax
n/a n/a n/a 30.71M
Change in Working Capital
-4.38M -1.79M -5.89M -18.26M
Operating Cash Flow
-56.02M -37.01M -43.48M -65.67M
Capital Expenditures
-2.45M -331K -130K -4.15M
Cash Acquisitions
n/a n/a 1.73M 4.15M
Purchase of Investments
-157.01M -51.64M -78.21M -20.16M
Sales Maturities Of Investments
120.2M 51.97M 52.64M 90.38M
Other Investing Acitivies
18K 204K n/a -4.15M
Investing Cash Flow
-39.24M 208K -23.96M 66.06M
Debt Repayment
20M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-1.49M -332K -5K 831K
Financial Cash Flow
104.14M 37.06M 43.17M 24.86M
Net Cash Flow
8.88M 256K -24.27M 25.26M
Free Cash Flow
-58.46M -37.34M -43.61M -69.82M